Article: Recommencement of atezolizumab with associated pulmonary sarcoid-like reaction.
2024 Volume 12, Issue 5, Page(s) e01363
Abstract: An 81 year old male with Child-Pugh A cirrhosis and metastatic hepatocellular carcinoma (HCC) treated with 3-weekly atezolizumab and bevacizumab developed a pulmonary sarcoid-like reaction (SLR) after 5 months. Atezolizumab, an immune checkpoint ... ...
Abstract | An 81 year old male with Child-Pugh A cirrhosis and metastatic hepatocellular carcinoma (HCC) treated with 3-weekly atezolizumab and bevacizumab developed a pulmonary sarcoid-like reaction (SLR) after 5 months. Atezolizumab, an immune checkpoint inhibitor, was identified as the likely culprit. He was treated with prednisolone, resulting in improvement, and was successfully rechallenged with both atezolizumab and bevacizumab. |
---|---|
Language | English |
Publishing date | 2024-04-26 |
Publishing country | United States |
Document type | Case Reports |
ZDB-ID | 2750180-2 |
ISSN | 2051-3380 |
ISSN | 2051-3380 |
DOI | 10.1002/rcr2.1363 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.